The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude

Clinical trial NCT07517068 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07517068
Sponsor: University of California, Riverside
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hypoxemia Acute Mountain Sickness (AMS)Inflammation Immune Response

Start date: 2025-09-17
Primary completion: 2026-06-15
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.